• Clinical trial simulation
    • Applications across R&D
  • jinkō
  • Resources
    • Publications & posters
    • White papers
    • Therapeutic areas
    • Case studies & deep dives
    • eBook
    • Webinars & tutorials
    • Glossary
  • Blog
  • About us
    • Leadership
    • Our clients
  • Careers
  • Try jinkō
  • jinkō’mmunity
Home > Resources > White papers

White papers

  • Publications & posters
  • Case studies & deep dives
  • Therapeutic areas
  • White papers
  • eBook
  • Webinars & tutorials
  • Glossary
Reset filters
Publication date: Mar 01, 2022

New methods for improving external control arms

External Control Arms (ECA) address some of the practical, ethical and cost challenges of recruiting in-trial randomized control arms. Yet ECAs have their own limitations.
Learn more
Publication date: Jan 12, 2021

Model-informed Drug Development (MiDD) at nova

Nova’s modeling and simulation approach combines mathematical models of diseases and treatments with virtual patients into an integrated clinical trial simulation platform called jinkō.
Learn more
Publication date: Nov 20, 2020

In silico clinical trials

In silico is emerging as the 3rd pillar of the drug R&D paradigm, in support of - not a full substitute to - more conventional in vitro and in vivo exploration and evidence-generation techniques.
Learn more
See more
Resources
  • Publications & posters
  • White papers
  • Case studies & deep dives
  • Webinars & tutorials
  • eBook
  • Blog
  • Glossary
jinkō'mmunity
Join nova

We pride ourselves on attracting the most talented individuals in our industry. Our interdisciplinary team combines expertise in biology, medicine, clinical pharmacology, applied mathematics, data science, artificial intelligence and software development.

See all vacancies
Demo request

Want to try the first collaborative clinical trial simulation platform?

Combining the power of data science, biology and medicine, jinkō predicts clinical outcomes of trials in human subjects.

Book a demo now!
Try jinkō
© Nova 2023
  • Legal notice
  • Privacy policy
  • Contact us
Follow us